NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Chairman/CEO Thomas A. Moore of Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, presents recent updates to the investment community concerning the company at the 2010 BIO International Convention in Chicago, IL.
